Kidney Dialysis Centers NAICS 621492

Sep 9, 2025 - FDA Approves First Large-Scale Human Trials of Pig Kidney Transplants

• The US Food and Drug Administration has approved large-scale human trials of kidney transplants involving genetically modified pig kidneys developed by Biotechnology company eGenesis, according to CNN. eGenesis’ pigs are genetically modified so that their organs are more compatible with human recipients. A few such transplants, called xenotransplants, have been performed in the US. In all of those cases, the patients had run out of other options and the organs were transplanted not through a standard clinical trial, but under special rules that permit compassionate use of experimental therapies for people in dire situations. Over 100,000 people in the US are waiting for an organ donation, and 86% of those on the list need a kidney. The average wait time for a kidney is three to five years at most centers, according to CNN.
• President Trump has signed into law the $3.4 trillion One Big Beautiful Bill that is estimated by Healio to include $930 billion in Medicaid cuts over 10 years. Kidney dialysis centers earn the majority of their revenue through reimbursements from Medicare and Medicaid. Nearly 12 million more people may be uninsured by 2034, with many losing coverage because of the Medicaid provisions in the bill, according to a US Congressional Budget Office analysis. For the first time in the Medicaid program’s nearly 60-year history, certain able-bodied adults aged 19 years to 64 years will be required to work, participate in job training, volunteer, or enroll in school at least 80 hours a month to maintain their Medicaid benefits. This will also be required for parents of children aged 14 years and older.

• Fewer patients starting dialysis are enrolling in Medicare since the introduction of the Affordable Care Act (ACA) in 2014 and are instead opting for private insurance, according to a study published in in JAMA Health Forum. The ACA expanded access to private insurance by preventing plans from denying coverage because of preexisting conditions, promoting state insurance exchanges, and relaxing special enrollment periods. “Dialysis expenditures for privately insurance patients were at least twice as high as patients with Medicaid who enrolled in Medicare after dialysis initiation and several times higher for patients with Medicaid who did not enroll in Medicare,” the investigators note. “This may lead to unnecessarily high overall societal costs and inequitable access to care for some patients, which ultimately affects payers, patients, and overall consumers (ie, overall consumer health care insurance premiums are not limited to patients with ESKD).”
• Kidney dialysis center industry employment decreased slightly and average wages for nonsupervisory employees increased slightly during the first five months of 2025, according to the US Bureau of Labor Statistics. Kidney dialysis industry sales are forecast to increase at a 5.75% compounded annual rate from 2025 to 2029, faster than the growth of the overall economy, according to Inforum and the Interindustry Economic Research Fund, Inc.